Direct costs of managing in-ward dengue patients in Sri Lanka: A prospective study.

<h4>Introduction</h4>The cost in managing hospitalised dengue patients varies across countries depending on access to healthcare, management guidelines, and state sponsored subsidies. For health budget planning, locally relevant, accurate costing data from prospective studies, is essenti...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chathurani Sigera, Chaturaka Rodrigo, Nipun L de Silva, Praveen Weeratunga, Deepika Fernando, Senaka Rajapakse
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/6e91efd6dbc346c5b1fd4d0a5d231ebb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6e91efd6dbc346c5b1fd4d0a5d231ebb
record_format	dspace
spelling	oai:doaj.org-article:6e91efd6dbc346c5b1fd4d0a5d231ebb2021-12-02T20:17:07ZDirect costs of managing in-ward dengue patients in Sri Lanka: A prospective study.1932-620310.1371/journal.pone.0258388https://doaj.org/article/6e91efd6dbc346c5b1fd4d0a5d231ebb2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0258388https://doaj.org/toc/1932-6203<h4>Introduction</h4>The cost in managing hospitalised dengue patients varies across countries depending on access to healthcare, management guidelines, and state sponsored subsidies. For health budget planning, locally relevant, accurate costing data from prospective studies, is essential.<h4>Objective</h4>To characterise the direct costs of managing hospitalised patients with suspected dengue infection in Sri Lanka.<h4>Methods</h4>Colombo Dengue Study is a prospective single centre cohort study in Sri Lanka recruiting suspected hospitalised dengue fever patients in the first three days of fever and following them up until discharge. The diagnosis of dengue is retrospectively confirmed and the cohort therefore has a group of non-dengue fever patients with a phenotypically similar illness, managed as dengue while in hospital. The direct costs of hospital admission (base and investigation costs, excluding medication) were calculated for all recruited patients and compared between dengue and non-dengue categories as well as across subgroups (demographic, clinical or temporal) within each of these categories. We also explored if excluding dengue upfront, would lead to an overall cost saving in several hypothetical scenarios.<h4>Results</h4>From October 2017 to February 2020, 431 adult dengue patients and 256 non-dengue fever patients were recruited. The hospitalisation costs were USD 18.02 (SD: 4.42) and USD 17.55 (SD: 4.09) per patient per day for dengue and non-dengue patients respectively (p>0.05). Laboratory investigations (haematological, biochemical and imaging) accounted for more than 50% of the total cost. The costs were largely homogenous in all subgroups within or across dengue and non-dengue categories. Excluding dengue upfront by subsidised viral genomic testing may yield overall cost savings for non-dengue patients.<h4>Conclusion</h4>As non-dengue patients incur a similar cost per day as the dengue patients, confirming dengue diagnosis using subsidised tests for patients presenting in the first three days of fever may be cost-efficient.Chathurani SigeraChaturaka RodrigoNipun L de SilvaPraveen WeeratungaDeepika FernandoSenaka RajapaksePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 10, p e0258388 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Chathurani Sigera Chaturaka Rodrigo Nipun L de Silva Praveen Weeratunga Deepika Fernando Senaka Rajapakse Direct costs of managing in-ward dengue patients in Sri Lanka: A prospective study.
description	<h4>Introduction</h4>The cost in managing hospitalised dengue patients varies across countries depending on access to healthcare, management guidelines, and state sponsored subsidies. For health budget planning, locally relevant, accurate costing data from prospective studies, is essential.<h4>Objective</h4>To characterise the direct costs of managing hospitalised patients with suspected dengue infection in Sri Lanka.<h4>Methods</h4>Colombo Dengue Study is a prospective single centre cohort study in Sri Lanka recruiting suspected hospitalised dengue fever patients in the first three days of fever and following them up until discharge. The diagnosis of dengue is retrospectively confirmed and the cohort therefore has a group of non-dengue fever patients with a phenotypically similar illness, managed as dengue while in hospital. The direct costs of hospital admission (base and investigation costs, excluding medication) were calculated for all recruited patients and compared between dengue and non-dengue categories as well as across subgroups (demographic, clinical or temporal) within each of these categories. We also explored if excluding dengue upfront, would lead to an overall cost saving in several hypothetical scenarios.<h4>Results</h4>From October 2017 to February 2020, 431 adult dengue patients and 256 non-dengue fever patients were recruited. The hospitalisation costs were USD 18.02 (SD: 4.42) and USD 17.55 (SD: 4.09) per patient per day for dengue and non-dengue patients respectively (p>0.05). Laboratory investigations (haematological, biochemical and imaging) accounted for more than 50% of the total cost. The costs were largely homogenous in all subgroups within or across dengue and non-dengue categories. Excluding dengue upfront by subsidised viral genomic testing may yield overall cost savings for non-dengue patients.<h4>Conclusion</h4>As non-dengue patients incur a similar cost per day as the dengue patients, confirming dengue diagnosis using subsidised tests for patients presenting in the first three days of fever may be cost-efficient.
format	article
author	Chathurani Sigera Chaturaka Rodrigo Nipun L de Silva Praveen Weeratunga Deepika Fernando Senaka Rajapakse
author_facet	Chathurani Sigera Chaturaka Rodrigo Nipun L de Silva Praveen Weeratunga Deepika Fernando Senaka Rajapakse
author_sort	Chathurani Sigera
title	Direct costs of managing in-ward dengue patients in Sri Lanka: A prospective study.
title_short	Direct costs of managing in-ward dengue patients in Sri Lanka: A prospective study.
title_full	Direct costs of managing in-ward dengue patients in Sri Lanka: A prospective study.
title_fullStr	Direct costs of managing in-ward dengue patients in Sri Lanka: A prospective study.
title_full_unstemmed	Direct costs of managing in-ward dengue patients in Sri Lanka: A prospective study.
title_sort	direct costs of managing in-ward dengue patients in sri lanka: a prospective study.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/6e91efd6dbc346c5b1fd4d0a5d231ebb
work_keys_str_mv	AT chathuranisigera directcostsofmanaginginwarddenguepatientsinsrilankaaprospectivestudy AT chaturakarodrigo directcostsofmanaginginwarddenguepatientsinsrilankaaprospectivestudy AT nipunldesilva directcostsofmanaginginwarddenguepatientsinsrilankaaprospectivestudy AT praveenweeratunga directcostsofmanaginginwarddenguepatientsinsrilankaaprospectivestudy AT deepikafernando directcostsofmanaginginwarddenguepatientsinsrilankaaprospectivestudy AT senakarajapakse directcostsofmanaginginwarddenguepatientsinsrilankaaprospectivestudy
_version_	1718374409550430208

Direct costs of managing in-ward dengue patients in Sri Lanka: A prospective study.

Ejemplares similares